Flow cytometric analysis of HIV-1–specific immune responses by intracellular cytokine staining

TH Timothy J. Henrich
HH Hiroyu Hatano
OB Oliver Bacon
LH Louise E. Hogan
RR Rachel Rutishauser
AH Alison Hill
MK Mary F. Kearney
EA Elizabeth M. Anderson
SB Susan P. Buchbinder
SC Stephanie E. Cohen
MA Mohamed Abdel-Mohsen
CP Christopher W. Pohlmeyer
RF Remi Fromentin
RH Rebecca Hoh
AL Albert Y. Liu
JM Joseph M. McCune
JS Jonathan Spindler
KM Kelly Metcalf-Pate
KH Kristen S. Hobbs
CT Cassandra Thanh
EG Erica A. Gibson
DK Daniel R. Kuritzkes
RS Robert F. Siliciano
RP Richard W. Price
DR Douglas D. Richman
NC Nicolas Chomont
JS Janet D. Siliciano
JM John W. Mellors
SY Steven A. Yukl
JB Joel N. Blankson
TL Teri Liegler
SD Steven G. Deeks
request Request a Protocol
ask Ask a question
Favorite

After thawing, PBMCs were incubated at 37°C overnight at a concentration of 2 × 106 cells/mL in RPMI medium containing 10% FBS and penicillin/streptomycin. The next day, 1 × 106 cells were stimulated with Gag pooled peptides (final concentration 1 μg/mL in DMSO provided by the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: HIV-1 Con B Gag Peptide Pool cat #12425), for 6 hours in the presence of brefeldin A and monensin (BD). The percentage of CD8+ or CD4+ T cells producing interferon gamma (PE-dazzle, clone 4S.B3, Biolegend), tumor necrosis factor alpha (Alexa fluor 700, clone mAb11, eBioscience) or interleukin-2 (BV785, clone MQ1-17H12, Biolegend), or degranulation as detected by CD107a expression (APC, clone H4A3, Biolegend), was measured by flow cytometry, and the frequency of positive cells was determined after subtraction of the frequency measured in wells incubated with DMSO alone. Examples of gating strategies are shown in S2 Fig.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A